Sign in

NCT07579780Recruiting

Superior HypogastrIc plExus bLock During Laparoscopic Colorectal Cancer Surgery

Superior Hypogastric Plexus Block for Early Recovery After Laparoscopic Colorectal Cancer Surgery: A Randomized Controlled Trial

Source: ClinicalTrials.gov · Last updated 12 May 2026

Brief summary (registry, in English)

This trial seeks to assess the efficacy of a superior hypogastric plexus block for early quality of recovery after laparoscopic colorectal cancer surgery.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
170 (estimated)
First submitted
28 Apr 2026
Start date
15 Dec 2025
Primary completion date
18 Dec 2026
Lead sponsor
Sixth Affiliated Hospital, Sun Yat-sen University
NCT number
NCT07579780

What you commit to

  • Study type: Interventional
  • Planned participants: 170
  • From 15 Dec 2025 to the primary completion date, 18 Dec 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Allergy to block medication (s).
  • Local or systemic infection.

Other

  • Coagulation dysfunction.
  • Unable to cooperate with the completion of the study protocol.

Who the study is looking for

  • Able to provide informed consent.
  • Undergoing elective laparoscopic radical resection for colorectal cancer.
  • American Society of Anesthesiologists Physical Status (ASA) class I-III.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
The Sixth Affiliated Hospital of Sun Yet-set University
Coordinator of this site? Confirm its status
GuangzhouChinaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.